title: Effect of n-3 long chain polyunsaturated fatty acids during the perinatal period on later body composition.
abstract: A systematic review to identify studies reporting the effects of n-3 long chain polyunsaturated fatty acids (LCPUFA) intake, during pregnancy and postnatally, on infants and young children's body composition was performed. A structured search strategy was performed in the MEDLINE (PubMed), EMBASE, and LILACS databases. Inclusion and exclusion criteria were defined according to the research question. Only those studies addressing the relationship between n-3 LCPUFA exposure during the perinatal period and later adiposity measured in terms of weight, height, body mass index (BMI), skinfold thickness and/or circumferences were included regardless of the study design. Studies quality was scored and were thereafter categorised into those reporting on maternal intake of n-3 LCPUFA during pregnancy or lactation (6 publications) or on infant's n-3 LCPUFA intake (7 publications). Two studies showed inverse associations between maternal n-3 LCPUFA intake and children's later body composition (lower adiposity, BMI or body weight), two showed direct associations and no effects were observed in the remaining two studies. Among those studies focusing on n-3 LCPUFA intake through enriched infant formulas; three observed no effect on later body composition and two showed higher weight and adiposity with increased amounts of n-3 LCPUFA. Reversely, in two studies weight and fat mass decreased. In conclusion, reported body composition differences in infants and young children were not clearly explained by perinatal n-3 LCPUFA intake via supplemented formulas, breastfeeding or maternal intakes of n-3 LCPUFA during pregnancy and lactation. Associated operational mechanisms including n-3 LCPUFA doses and sources applied are not sufficiently explained and therefore no conclusions could be made.
authors.affiliation: GENUD (Growth, Excercise, NUtrition and Development) Research Group, University of Zaragoza, Zaragoza, Spain. gereva@comz.org
authors.forename: G
authors.initials: G
authors.lastname: Rodríguez
authors.forename: I
authors.initials: I
authors.lastname: Iglesia
authors.forename: S
authors.initials: S
authors.lastname: Bel-Serrat
authors.forename: L A
authors.initials: LA
authors.lastname: Moreno
mesh_terms: D000273:Adipose Tissue / Q000187:drug effects*; D050154:Adiposity / Q000187:drug effects; D001823:Body Composition / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects*; D004032:Diet; D019587:Dietary Supplements; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology*; D005260:Female; D006801:Humans; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D009765:Obesity / Q000209:etiology; D011247:Pregnancy; D039401:Prenatal Nutritional Physiological Phenomena
chemical_list: D015525:Fatty Acids, Omega-3